Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Filings indexed 2,766 across all filing types
Latest filing 2022-11-21 Director's Dealing
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2022-11-21 English
PRIMARY DOCUMENT
Director's Dealing
2022-11-21 English
CURRENT REPORT
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by CVS Health Corporation. It reports amendments to the company's bylaws related to corporate governance and announces a new $10 billion share repurchase program. The document includes a description of the bylaw changes and the repurchase program authorization but does not contain detailed financial statements or comprehensive financial analysis. It also attaches the amended bylaws as an exhibit. The content focuses on governance changes and capital activity (share repurchase program). Given the nature of the amendments to bylaws and the governance-related content, the primary classification aligns with Board/Management Information (MANG). However, the announcement of the repurchase program is a capital/financing update. Since the document prominently features governance amendments and the repurchase program authorization, the best fitting category is Board/Management Information (MANG), as the repurchase program is an authorization rather than a detailed financing update. The document length is 4695 characters, which is sufficient for a substantive filing, not a mere announcement. Therefore, the classification is MANG with high confidence.
2022-11-21 English
Regulatory Filings 2022
Regulatory Filings
2022-11-10 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-02 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce material events. The key section is Item 2.02 "Results of Operations and Financial Condition," which states that CVS Health Corporation issued a press release announcing results for the three months ended September 30, 2022. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release as an exhibit. The document length is 3689 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, if a document is short and announces or furnishes a report (like a press release of earnings), it should be classified as a Regulatory Filing (RNS) rather than an Earnings Release (ER) or Interim Report (IR) because the actual financial data is in the press release exhibit, not in the 8-K text itself. Therefore, the best classification is Regulatory Filings (RNS).
2022-11-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.